Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lixte Biotechnology Holdings (LIXT) Assets (2016)

Lixte Biotechnology Holdings' Assets history spans 7 years, with the latest figure at $933561.0 for Q3 2016.

  • For Q3 2016, Assets fell 9.1% year-over-year to $933561.0; the TTM value through Sep 2016 reached $933561.0, down 9.1%, while the annual FY2015 figure was $597975.0, N/A changed from the prior year.
  • Assets reached $933561.0 in Q3 2016 per LIXT's latest filing, down from $1.4 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $2.3 million in Q2 2012 to a low of $187867.0 in Q1 2014.
  • Average Assets over 5 years is $1.2 million, with a median of $1.2 million recorded in 2013.
  • Peak YoY movement for Assets: crashed 87.32% in 2014, then skyrocketed 795.32% in 2015.
  • A 5-year view of Assets shows it stood at $1.8 million in 2012, then tumbled by 68.17% to $558040.0 in 2013, then skyrocketed by 78.51% to $996170.0 in 2014, then plummeted by 39.97% to $597975.0 in 2015, then soared by 56.12% to $933561.0 in 2016.
  • Per Business Quant, the three most recent readings for LIXT's Assets are $933561.0 (Q3 2016), $1.4 million (Q2 2016), and $1.2 million (Q1 2016).